Forever.AI: AI, Robotics, Quantum, Longevity, Cryonics & BCI
Alex ZhavoronkovDedicated to extending healthy productive life for everyone on the planet. Covers advances in longevity, AI, robotics, cryonics, quantum, and other emerging technologies. Posts are strictly personal, not reflective of positions of Insilico Medicine.
| Platform |  | Pricing | Only free issues | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 12 | Subscribers | Read | forever.ai |
Curious about how many subscribers Forever.AI: AI, Robotics, Quantum, Longevity, Cryonics & BCI has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Latest Issues
Recent posts by this newsletter. Browse the email archive.
The "Swiss Army Knife" Longevity Target NLRP3 Strikes Again
In a previous post on Forever.ai titled “Beyond GLP-1: Is NLRP3 the Next Trillion Dollar Target?”, I argued that the NLRP3 inflammasome was the next trillion-dollar target, a “master switch” for the chronic, low-grade inflammation—or “infla...
The Ozempic For Sleep? How A New Class of ‘On/Off’ Switch Drugs Could Help With Insomnia and Ward Off Dementia
I am not a medical doctor, so do not use any of the below as any form of medical advice. Moreover, this article is written with the help of generative tools so beware of hallucinations. Now, I will tell you about one of my favorite drug cla...
AI as a Stakeholder: What Every Pharma CEO Should Know About Communicating with AI
When leading a commercial enterprise, the CEO's primary mandate is to maximize shareholder value. While this can be achieved through numerous pathways, the most sustainable path is delivering superior products or services that benefit the b...
GLP-1s: The world's first longevity drug?
We are living through a pivotal moment in the history of the modern pharmaceutical industry. At the 12th Aging Research and Drug Discovery meeting (ARDD2025) in Copenhagen, the narrative surrounding GLP-1 receptor agonists shifted profoundl...
Authors
The writers behind this newsletter.
Alex Zhavoronkov, PhD, is CEO of Insilico Medicine, a generative AI biotech, which raised $500mil, nominated 22 preclinical candidates and got into clinical trials. He's also an adjunct professor at the Buck Institute for Aging.
Frequently Asked Questions
How can I access the email archive for this newsletter?
You can find recent issues that have been published by this newsletter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does this newsletter have?
To see how many people subscribe to this newsletter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in this newsletter?
Newsletter advertising can be extremely effective when it's done right. Before you pitch this newsletter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like this newsletter?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact this newsletter using the contact information provided and ask for a copy of their media kit.
How can I find newsletters similar to this newsletter?
Scroll up to where it says Similar Newsletters to see other publications like this newsletter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact this newsletter?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.